Home › NDC Lookup › RxCUI directory › RxCUI 259081

12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule — RxCUI 259081

RxNorm drug concept · Semantic clinical drug
RxCUI 259081 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI259081
Official name12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as12 HR ASA 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule; aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule
FDA products mapped9
Package NDCs mapped10
Reported Medicaid activity (SDUD)1,220 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
  • Why would someone use a rectal suppository instead of just taking aspirin by mouth?
  • First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
  • This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...
📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How 12 HR aspirin 25 MG / dipyridamole 200 MG Extend... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule RxCUI 259081

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
    • Dipyridamole 3521
    • Aspirin / dipyridamole 226716
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin / dipyridamole Extended Release Oral Capsule 1856538
    • Aspirin / dipyridamole Oral Product 1153731
    • Aspirin / dipyridamole Pill 1153732
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Aspirin 25 MG 329295
    • Dipyridamole 200 MG 329296

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aspirin 25 MG SCDC · 329295
  • Dipyridamole 200 MG SCDC · 329296
  • Aspirin / dipyridamole Extended Release Oral Capsule SCDF · 1856538
  • Aspirin / dipyridamole Oral Product SCDG · 1153731
  • Aspirin / dipyridamole Pill SCDG · 1153732

📦 FDA Products & Package NDCs

9 products · 10 package NDCs
10 package NDCs map to RxCUI 259081 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-7056-99 20 BLISTER PACK in 1 CARTON (0904-7056-99) / 1 CAPSULE in 1... Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg Major Pharmaceuticals 2017-01-30
16714-0964-01 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01) Aspirin and Dipyridamole NorthStar Rx LLC 2019-04-03
42291-0116-60 60 CAPSULE in 1 BOTTLE (42291-116-60) Aspirin and Extended-Release Dipyridamole AvKARE 2017-04-27
42571-0274-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60) ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE Micro Labs Limited 2021-08-16
43598-0339-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60) Aspirin and Dipyridamole Dr. Reddy's Laboratories Inc 2018-10-10
49884-0007-02 60 CAPSULE in 1 BOTTLE (49884-007-02) Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg Endo USA, Inc. 2017-01-30
63629-5045-01 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-5045-1) ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE Bryant Ranch Prepack 2025-01-28
65162-0596-06 60 CAPSULE in 1 BOTTLE (65162-596-06) Aspirin and Extended-Release Dipyridamole Amneal Pharmaceuticals LLC 2016-03-28
68462-0405-30 30 CAPSULE in 1 BOTTLE (68462-405-30) ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE Glenmark Pharmaceuticals Inc., USA 2019-05-24
68462-0405-60 60 CAPSULE in 1 BOTTLE (68462-405-60) ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE Glenmark Pharmaceuticals Inc., USA 2019-05-24
Observed labelers: Glenmark Pharmaceuticals Inc., USA (2) · Amneal Pharmaceuticals LLC (1) · AvKARE (1) · Bryant Ranch Prepack (1) · Dr. Reddy's Laboratories Inc (1) · Endo USA, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.